tag:blogger.com,1999:blog-36634196.post1749314199221938697..comments2023-10-09T11:33:37.853-05:00Comments on The IN VIVO Blog: Making Friends for FDAChris Morrisonhttp://www.blogger.com/profile/04075266444951558159noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-36634196.post-44132813777584044382008-04-13T13:54:00.000-05:002008-04-13T13:54:00.000-05:00If we want to get new therapies to patients faster...If we want to get new therapies to patients faster, the federal agency whose budget we should be doubling right now is not the NIH’s but the FDA’s. After years of an expanding mission and a shrinking budget, in 2007 the FDA was finally given new authorities and some new resources to try to keep up with the tide of new technologies, methodologies, and products aspiring to or already in the marketplace. The question is, will Congress and the agency itself follow through on the promise? The first step was not promising, as Congress withheld funding for the Reagan-Udall Foundation, newly created to support FDA’s important Critical Path initiative. Everyone who cares about cures needs to be watching.<BR/><BR/>Greg Simon<BR/>President, FasterCuresAnonymousnoreply@blogger.com